Market Highlights
Single-Photon Emission Computed Tomography
Market size is expected to reach
at 6.90% CAGR during the forecast period 2023-2032. The growing acceptance of
Single-Photon Emission Computed Tomography (SPECT) accustomed by its technical
advances is one of the major trends witnessed in the global SPECT market over
the forecast period. Imaging devices are becoming more advanced, efficient, and
evolved in terms of technology. The SPECT scanner has two integral parts namely
computed tomography (CT) and a radioactive material (tracer). Basically, these
tracers are used to diagnose and predict outcomes in various disease states by
monitoring the therapeutic effects.
The Single-Photon Emission Computed
Tomography (SPECT) market is expected to witness tremendous growth owing
to the new 99mtc labelled agents for visualizing biologically significant
events, and integration of X-ray tomography (CT) In SPECT. Other key factors
such significant investments in R&D and expansions undertaken by key
players are contributing towards the growth of the market. However, challenges
such as need for skilled professionals, and reimbursement issues, is likely to
curb the market growth during the forecast period.
Key players
The global market is manifested with the
presence of limited companies, leading to the consolidated nature of the
market. The industry rivalry are expected to remain high throughout the
forecast period. Several small and larger companies are involved in development
of Single-Photon Emission Computed Tomography (SPECT) for diagnostic
applications.
The Single-Photon Emission Computed
Tomography Market Players are GE Healthcare, Siemens Healthcare, Koninklijke
Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum
Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing
Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
PNPMedM, NuCare Inc., and others.
Segmentation
The global Single-Photon Emission Computed Tomography
(SPECT) market is segmented into
type, application, end-users. The Single-Photon Emission Computed Tomography
(SPECT) market, by type, the market is segmented into hybrid SPECT systems, and
standalone SPECT systems. On the basis of application, the Single-Photon
Emission Computed Tomography (SPECT) market is bifurcated into oncology,
cardiology, neurology, and others. On the basis of end-user, the market is
segmented into hospitals, diagnostic imaging centers, academic & research
centers, and others.
Regional Analysis
The Americas is the largest in the market
owing to the improving research infrastructure in the region, coupled with the
rising awareness among patients and physicians for radioisotopes. Further,
SPECT has reportedly been combined with CT and MRI to provide detailed
anatomical and metabolic information. It is currently exhibiting a highly
lucrative growth rate due to an increased use of SPECT for diagnosis of cardiac
diseases, brain diseases, etc.
The European region is the second largest
SPECT market over the forecast period due to high acceptance of SPECT in
research & development along with the rising incidence of chronic disease
like cancers are also accountable for the growth of the Single-Photon Emission
Computed Tomography (SPECT) market.
The Asia Pacific region is likely to develop
at the uppermost CAGR for the Single-Photon Emission Computed Tomography
(SPECT) market in the years to come. Moreover, the rising diagnostic care
services both at the hospitals and at community level are expected to influence
the market in a positive way. The Middle East and Africa accounts for the least
market share due to low per capita income and lack of availability of
well-trained healthcare professionals.
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
No comments:
Post a Comment